Paper
Lyme Disease: A Role for Coenzyme Q10 Supplementation?
Published Mar 30, 2022 · D. Mantle, Nadia Turton, I. Hargreaves
Antioxidants
1
Citations
0
Influential Citations
Abstract
Lyme disease results from a bacterial infection following a bite from an infected tick. Patients are initially treated with antibiotics; however, in cases where antibiotic treatment is delayed, or when patients do not respond to antibiotic treatment, fatigue may develop alongside problems affecting the nervous system, cardiovascular system, and joints. It is thought that most of the damage to these tissues results from the excessive inflammatory response of the host, involving a self-reinforcing cycle of mitochondrial dysfunction, oxidative stress and inflammation. In this article, we review the potential role of supplementary coenzyme Q10 (CoQ10) in mediating the pathogenic mechanism underlying Lyme disease, on the basis of its role in mitochondrial function, as well as its anti-inflammatory and antioxidant actions.
Coenzyme Q10 supplementation may play a role in mediating the pathogenic mechanism underlying Lyme disease, due to its role in mitochondrial function, anti-inflammatory, and antioxidant actions.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...